Paladin's strategy is to leverage its strong sales and marketing capabilities with the acquisition and in-licensing of complementary products. Continued growth will be fueled by the launch of innovative products - principally sourced from small to medium sized pharmaceutical and biotechnology companies with promising technology but no sales and marketing capabilities in Canada.

Based on our proven track record for marketing and selling innovative pharmaceuticals in Canada, Paladin will become the partner of choice for these emerging new companies.